In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, LifeMD Inc’s stock clocked out at $10.64, up 0.57% from its previous closing price of $10.58. In other words, the price has increased by $0.57 from its previous closing price. On the day, 2.17 million shares were traded. LFMD stock price reached its highest trading level at $11.18 during the session, while it also had its lowest trading level at $10.1504.
Ratios:
To gain a deeper understanding of LFMD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.69. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 0.82.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’25 when Schreiber Justin sold 21,995 shares for $7.53 per share. The transaction valued at 165,684 led to the insider holds 2,553,726 shares of the business.
Schreiber Justin sold 3,005 shares of LFMD for $22,539 on May 02 ’25. The Chairman and CEO now owns 2,550,721 shares after completing the transaction at $7.50 per share. On Apr 29 ’25, another insider, Schreiber Justin, who serves as the Chairman and CEO of the company, sold 50,000 shares for $7.78 each. As a result, the insider received 389,040 and left with 2,575,721 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 483562464 and an Enterprise Value of 476204000. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07. Its current Enterprise Value per Revenue stands at 2.035 whereas that against EBITDA is -81.195.
Stock Price History:
The Beta on a monthly basis for LFMD is 2.35, which has changed by 0.36585367 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $10.99, while it has fallen to a 52-week low of $3.99. The 50-Day Moving Average of the stock is 62.77%, while the 200-Day Moving Average is calculated to be 87.90%.
Shares Statistics:
It appears that LFMD traded 1.80M shares on average per day over the past three months and 2144780 shares per day over the past ten days. A total of 43.53M shares are outstanding, with a floating share count of 36.13M. Insiders hold about 20.51% of the company’s shares, while institutions hold 36.38% stake in the company. Shares short for LFMD as of 1745971200 were 5341633 with a Short Ratio of 2.97, compared to 1743379200 on 7414929. Therefore, it implies a Short% of Shares Outstanding of 5341633 and a Short% of Float of 14.829998999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1.0 analysts currently analyzing and rating the stock of LifeMD Inc (LFMD).The consensus estimate for the next quarter is $0.16, with high estimates of $0.16 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.64 and $0.0 for the fiscal current year, implying an average EPS of $0.32. EPS for the following year is $0.6, with 2.0 analysts recommending between $0.95 and $0.25.
Revenue Estimates
In the current quarter, 9 analysts expect revenue to total $66.17M. It ranges from a high estimate of $67.71M to a low estimate of $65.09M. As of the current estimate, LifeMD Inc’s year-ago sales were $50.66MFor the next quarter, 9 analysts are estimating revenue of $67.96M. There is a high estimate of $69.59M for the next quarter, whereas the lowest estimate is $67M.
A total of 9 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $273.23M, while the lowest revenue estimate was $266.8M, resulting in an average revenue estimate of $270.14M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $316.6M in the next fiscal year. The high estimate is $355M and the low estimate is $297.5M.
